NCT00735579
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +11 more
- Locations
-
- Klinikum St. Georg gGmbH Leipzig, Saxony, Germany
Clinical trial condition
Coagulation Protein Disorders
Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.
784 public trials
106 recruiting studies
Coagulation Protein Disorders trial results
NCT02492984
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
- Locations
-
- The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
- Henan Provincial People's Hospital Zhengzhou, Henan, China
- Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
- Department of Hematology,The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Completed
Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A
NCT01138501
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Orange, California, United States
- Novo Nordisk Investigational Site Torrance, California, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
NCT00840086
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Little Rock, Arkansas, United States
- Novo Nordisk Investigational Site Long Beach, California, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
- Novo Nordisk Investigational Site Atlanta, Georgia, United States
NCT00486278
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
- Locations
-
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Augusta, Georgia, United States
- Novo Nordisk Investigational Site Chicago, Illinois, United States
- Novo Nordisk Investigational Site Indianapolis, Indiana, United States
NCT01555749
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
- Locations
-
- Novo Nordisk Investigational Site Harrow, United Kingdom
Completed
Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study.
NCT02851082
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
- Locations
-
- University Hospital of Toulouse Toulouse, France
NCT01322620
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +14 more
- Locations
-
- Novo Nordisk Investigational Site Mississauga, Canada
- Novo Nordisk Investigational Site Madrid, Spain
- Novo Nordisk Investigational Site Crawley, United Kingdom
NCT01365520
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Kuala Lumpur, Malaysia
- Novo Nordisk Investigational Site London, United Kingdom
- Novo Nordisk Investigational Site London, United Kingdom
Completed
Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects
NCT00837356
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Berlin, Germany
- Novo Nordisk Investigational Site Hanover, Germany
- Novo Nordisk Investigational Site Tel Litwinsky, Israel
- Novo Nordisk Investigational Site Florence, Italy